ARTICLE
24 August 2017

Appeal Of Federal Court's Decision Upholding Board's Finding Of Confusion Dismissed (Intellectual Property Weekly Abstracts - Week of August 21, 2017)

BL
Borden Ladner Gervais LLP

Contributor

BLG is a leading, national, full-service Canadian law firm focusing on business law, commercial litigation, and intellectual property solutions for our clients. BLG is one of the country’s largest law firms with more than 750 lawyers, intellectual property agents and other professionals in five cities across Canada.
In the present appeal, U-Haul submitted that the Federal Court erred by not conducting a de novo analysis and upholding the Board's conclusion of confusion.
Canada Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

Trademarks Decision

Appeal of Federal Court's decision upholding Board's finding of confusion dismissed

U-haul International Inc. v. U Box It Inc., 2017 FCA 170

The Court of Appeal dismissed U-Haul's appeal of the Federal Court's decision, which upheld the Opposition Board's decision allowing the opposition of U-Haul's two trademark applications of U-BOX and U-BOX WE-HAUL. The Board determined that U-Haul had failed to show that its two trademarks were not confusing with U Box It Inc.'s trademark, U BOX IT. On appeal, the Federal Court refused to conduct a de novo review as the new evidence would not have made a material difference in the Board's findings of fact or exercise of discretion. The Federal Court also concluded that the Board's finding of confusion was reasonable (see 2015 FC 1345, our summary here)

In the present appeal, U-Haul submitted that the Federal Court erred by not conducting a de novo analysis and upholding the Board's conclusion of confusion. The Court of Appeal found that the new evidence merely supplemented or confirmed the findings of the Board. The Court of Appeal also concluded that the Board's finding of confusion was reasonable, and that it was not appropriate to conduct a re-weighing exercise in this case.

Industry Updates

Health Canada published a Notice — Publication of the Health Canada Guidance Document: Use of Certificates of Suitability as supporting information in Drug Submissions.

Health Canada published a Notice — The Regulatory Enrolment Process (REP) Functional Pilot for eCTD Format — Stage III.

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More